CH624402A5 - Process for the preparation of novel heterocyclic derivatives of 1-alkyl-substituted 4-phenylpiperazine and use of the novel derivatives - Google Patents

Process for the preparation of novel heterocyclic derivatives of 1-alkyl-substituted 4-phenylpiperazine and use of the novel derivatives Download PDF

Info

Publication number
CH624402A5
CH624402A5 CH1140674A CH1140674A CH624402A5 CH 624402 A5 CH624402 A5 CH 624402A5 CH 1140674 A CH1140674 A CH 1140674A CH 1140674 A CH1140674 A CH 1140674A CH 624402 A5 CH624402 A5 CH 624402A5
Authority
CH
Switzerland
Prior art keywords
formula
piperazine
derivatives
ethyl
pyridyl
Prior art date
Application number
CH1140674A
Other languages
Italian (it)
Inventor
Mario Dr Giannini
Original Assignee
Malesci Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Malesci Sas filed Critical Malesci Sas
Publication of CH624402A5 publication Critical patent/CH624402A5/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Novel heterocyclic derivatives of 1-alkyl-substituted 4-phenylpiperazine of the formula X <IMAGE> in which X' is hydrogen, methyl or acyl, are prepared by reacting bromoacetylpyridine hydrobromide with a phenylpiperazine, directly reducing the ketones obtained with NaBH4 to alcohols of the formula X, chlorinating and alkylating the alcohols to prepare the alkoxy derivatives of the formula X. In the formula X, R2 is -H, -Cl, -F, -CH3 or -OCH3. The novel derivatives have a well-defined and efficacious therapeutic action as antihypertensives by vasodilation and alpha-blocking, and as antibradykinin antihistamines.

Description

30 La presente invenzione ha per oggetto un procedimento per la preparazione di nuovi derivati eterociclici della 4-fenil--piperazina-l-alchil-sostituita. Questi nuovi derivati posseggono un'azione farmacologica. 30 The present invention relates to a process for the preparation of new heterocyclic derivatives of 4-phenyl-piperazine-1-alkyl-substituted. These new derivatives have a pharmacological action.

Come è ben noto il crescente incremento delle affezioni 35 cardiovascolari dovute all'instaurarsi di stati di ipertensione funzionale e il diffondersi di sintomatologie imputabili a reazioni allergiche richiede continuamente ai settori di ricerca lo studio, la sperimentazione e la preparazione di ritrovati che presentino migliorate caratteristiche di attività terapeu-40 tica, con risultati nuovi o comunque di rilievo. As is well known, the growing increase in cardiovascular diseases 35 due to the onset of states of functional hypertension and the spread of symptoms attributable to allergic reactions requires the research sectors to continuously study, experiment and prepare products that have improved characteristics of therapeutic activity, with new or significant results.

A questo scopo sono risultati particolarmente adatti secondo questa invenzione alcuni derivati eterociclici della 4-fenil-piperazina-l-alchìl sostituita aventi una ben definita ed efficace azione terapeutica come antipertensivi, in quan-45 to vasodilatatori e alfa-bloccanti e come antiistaminici anti-brachidinici. For this purpose, some heterocyclic derivatives of substituted 4-phenyl-piperazine-1-alkyl having a well-defined and effective therapeutic action as antihypertensives, as vasodilators and alpha-blockers and as antihistamines anti- brachidinici.

Un oggetto di questa invenzione è un procedimento per la preparazione di nuovi derivati eterociclici della 4-fenil--piperazina-l-alchil-sostituita di formula IV An object of this invention is a process for the preparation of new heterocyclic derivatives of the 4-phenyl-piperazine-1-alkyl-substituted formula IV

50 50

ÇH— CH; ÇH— CH;

(VI) (YOU)

55 55

OH OH

O-Gf O-Gf

R, R,

(IV) (IV)

OX OX

m cui m cui

X è metile o etile caratterizzato dal fatto di X is methyl or ethyl characterized by the fact of

A) clorurare con SOCl2 in CHCl;t i derivati alcolici della formula IV, e A) chlorinate the alcohol derivatives of formula IV with SOCl2 in CHCl; t

B) aggiungere i cloro derivati non purificati ad una soluzione alcolica di metilato od etilato di sodio e isolare gli alcossi derivati ottenuti diluendo con acqua ed estraendo con etere i derivati della formula VI. B) add the uncleaned chlorine derivatives to an alcoholic solution of methylate or sodium ethylate and isolate the alkoxy derivatives obtained by diluting the derivatives of formula VI with water and extracting the ether with formula.

3. Utilizzazione secondo la rivendicazione 2, caratterizzata dal fatto che si prepara il l-[2-metossi-2-(3'-piridil)- Use according to claim 2, characterized in that the l- [2-methoxy-2- (3'-pyridyl) - is prepared

ìn cui in which

R2 è -H, -Cl, -F, -CH,, -OCH3. R2 is -H, -Cl, -F, -CH ,, -OCH3.

Questo procedimento è caratterizzato dal fatto di A) far reagire bromo-acetil-piridina bromidrato della 60 formula II This process is characterized by the fact of A) reacting bromo-acetyl-pyridine hydrochloride of 60 formula II

([ " C ■ CH^-~ Br • (["C ■ CH ^ - ~ Br •

^ I ^ I

con fenil-piperazina della formula III with phenyl-piperazine of formula III

HBr di) HBr of)

3 3

624402 624402

h h

- -

R, R,

sotto atmosfera di azoto, in alcool metilico, in presenza di trietilammina, formando il chetone della formula I under a nitrogen atmosphere, in methyl alcohol, in the presence of triethylamine, forming the ketone of the formula I

O- OR-

OUx OUX

R„ R "

E' stato infatti imprevedibilmente trovato, e ciò costituisce l'oggetto primario di questa invenzione, che la serie di derivati della 4-feniI-piperazina-alchil sostituita di formula (III) generale A presenta rilevante efficacia nella cura dei distur-5 bi indotti dall'alta pressione arteriosa e nella inibizione degli effetti provocati dalla istamina e dalla bradichinina. Questi derivati hanno azione antipertensiva, antiistaminica e an-tibrachidinica. In fact it has been unpredictably found, and this constitutes the primary object of this invention, that the series of derivatives of the substituted 4-phenyl-piperazine-alkyl of formula (III) A has significant efficacy in the treatment of the induced disturbances. by high blood pressure and in the inhibition of the effects caused by histamine and bradykinin. These derivatives have antihypertensive, antihistamine and anti-tibrachidinic action.

Tra detti derivati di formula generale A sono risultati io particolarmente preferibili quelli in cui i sostituenti R, R, e R, hanno rispettivamente le combinazioni significati e il valore indicati nella seguente tabella I. Among said derivatives of general formula A, the ones in which the substituents R, R, and R have the combinations meaning and the value indicated in the following table I are particularly preferable.

(I) (THE)

B) ridurre direttamente i chetoni ottenuti in (A) con NaBH4 ad alcoli della formula IV in soluzione idroalcolica. B) directly reduce the ketones obtained in (A) with NaBH4 to alcohols of formula IV in hydroalcoholic solution.

L'invenzione ha per oggetto anche l'utilizzazione di nuovi alcoli di formula IV The invention also relates to the use of new alcohols of formula IV

15 15

20 20

(IV) (IV)

OH OH

m cui m cui

R2 è -H, -Cl, -F, -CH3, -OCHa; R2 is -H, -Cl, -F, -CH3, -OCHa;

per la preparazione di nuovi derivati eterociclici della 4-fe-nil-piperazina-l-alchil-sostituita di formula VI for the preparation of new heterocyclic derivatives of 4-fe-nyl-piperazine-1-alkyl-substituted of formula VI

25 25

30 30

(VI) (YOU)

0X 0X

m cui m cui

X è metile o etile. X is methyl or ethyl.

Questa utilizzazione è caratterizzata dal fatto di This use is characterized by the fact of

A) clorurare con SOCl2 in CHCI3 i derivati alcolici della formula IV, e A) chlorinate the alcohol derivatives of formula IV with SOC1 in CHCI3, and

B) aggiungere i cloro derivati non purificati ad una soluzione alcolica di metilato od etilato di sodio e isolare gli alcossi derivati ottenuti diluendo con acqua ed estraendo con etere i derivati della formula VI. B) add the uncleaned chlorine derivatives to an alcoholic solution of methylate or sodium ethylate and isolate the alkoxy derivatives obtained by diluting the derivatives of formula VI with water and extracting the ether with formula.

I nuovi derivati eterociclici della 4-fenil-piperazina-l--alchil sostituita preparati secondo il procedimento della invenzione o secondo la utilizzazione della invenzione di formula IV e VI hanno la formula generale A The new heterocyclic derivatives of the substituted 4-phenyl-piperazine-1-alkyl prepared according to the process of the invention or according to the use of the invention of formula IV and VI have the general formula A

B-CH-K5H, B-CH-K5H,

i ' i '

R„ R "

-N N \ / -N N \ /

(A) (TO)

in cui in which

R è R is

0* 0 *

a preferenza preferably

Cr-Ò Cr-Ò

Ri è -OH, -OCH3 o -OC2H5 R2 è -H, -Cl, -F, -CH3 o -OCH-,. Ri is -OH, -OCH3 or -OC2H5 R2 is -H, -Cl, -F, -CH3 or -OCH- ,.

TABELLA 1 TABLE 1

Prodotto no. Product no.

R R

Ri Re

35 35

40 40

45 45

50 10 50 10

55 55

60 60

65 65

11 11

12 12

13 13

-oc.,h5 -oo., h5

-OH -OH

-OH -OH

-OH -OH

-OH -OH

-OH -OH

-OH -OH

-OH -OH

-OH -OH

-OH -OH

'N 'N

R2 R2

-CL.o -CL.o

-H -H

-OCH,. o OCH ,. or

-OCH3. m -OCH3. m

-OCH-i. p OCH-i. p

-CH.,. o CH.,. or

-ch,3. p -ch, 3. p

-Cl.o -Cl.o

-Cl.n -Cl.n

624402 624402

4 4

TABELLA 1 (continuazione) TABLE 1 (continued)

Prodotto Product

14 14

15 15

16 16

17 17

18 18

R R

Ri Re

-N -N

-OH -OH

-OH -OH

-OCH, OCH,

-OC2H, -OC2H,

-OCH, OCH,

Ra Ra

-CI.p -CI.p

-F. o -F. or

-H -H

-H -H

-OCH,. o per diluizione con acqua ed estrazione con etere. OCH ,. or by dilution with water and extraction with ether.

Per quanto riguarda i derivati piridilici, imidazolilici, e tetraidroisochinolilici c essi vengono ottenuti facendo reagire i cloro-alchil eterociclici in oggetto con la N-fenil piperazina 5 o con i suoi derivati in dimetilformammide (D.M.F.) in presenza di trietilammina. As regards pyridyl, imidazolyl, and tetrahydroisoquinolyl derivatives, they are obtained by reacting the heterocyclic chloro-alkyls in question with the N-phenyl piperazine 5 or with its derivatives in dimethylformamide (D.M.F.) in the presence of triethylamine.

In particolare per quanto riguarda i piridiletil derivati c questi possono anche venir prodotti secondo un'alternativa di procedimento, inclusa nell'ambito di questa invenzione, io facendo reagire gli intermedi chetonici ottenuti, in 1 previamente isolati e purificati, con idrazina in dietilenglicole, in presenza di sodio. In particular, as regards pyridylethyl derivatives, these can also be produced according to a process alternative, included in the scope of this invention, by reacting the ketone intermediates obtained, in 1 previously isolated and purified, with hydrazine in diethylene glycol, in presence of sodium.

In particolare per quanto riguarda i prodotti specifici riportati nella tabella I, gli schemi operativi di procedimento 15 di preparazione sono in generale i seguenti: In particular, as regards the specific products shown in Table I, the operating procedures of the preparation process 15 are in general the following:

(a) Derivati alcolici (prodotti 5-15, 21 e 22. (a) Alcoholic derivatives (products 5-15, 21 and 22.

Si fa reagire bromoacetilpiridina II con fenilpiperazina o suoi derivati III sotto azoto in alcool metilico, in presenza di trietilammina secondo lo schema di reazione seguente: Bromoacetylpyridine II is reacted with phenylpiperazine or its derivatives III under nitrogen in methyl alcohol, in the presence of triethylamine according to the following reaction scheme:

20 20

li - CO - CH2 - Br + li - CO - CH2 - Br +

<XJr- <XJr-

25 25

30 30

(II) (II)

(III) (III)

♦ rc(o2H5), ♦ rc (o2H5),

HeOH HeOH

G/=V* G / = V *

(VI) (YOU)

K-CO-CH^ K-CO-CH ^

19 19

-OC2Hö -OC2Hö

-OCH,. o OCH ,. or

20 20

21 21

22 22

-OCH, OCH,

-OH -OH

-OH -OH

-Cl. o -Cl. or

-OCH,. o OCH ,. or

-H -H

e successivamente riducendo i derivati chetonici VI con 35 NaBH4 in soluzione idroalcolica VIII and subsequently reducing the VI ketone derivatives with 35 NaBH4 in hydroalcoholic solution VIII

40 40

h-ch-cit-.it h-ch-cit-.it

I 2 I 2

oh Oh

2 2

V_y V_y

(Vili) (VIII)

in cui R e R2 soddisfano alle seguenti combinazioni di significati: where R and R2 satisfy the following combinations of meanings:

Per quanto riguarda le metodiche di preparazione dei derivati della 4-fenil-piperazina-l-alchil sostituita sono previsti secondo l'invenzione schemi operativi di procedimento diversi a seconda che si tratti di: As regards the preparation methods for the derivatives of the substituted 4-phenyl-piperazine-1-alkyl, different operating procedures are provided according to the invention according to whether they are:

(a) derivati alcolici (a) alcoholic derivatives

(b) derivati alcossilici (b) alkoxyl derivatives

(c) derivati piridilici. (c) pyridyl derivatives.

Il procedimento di base, in cui si innestano detti diversi schemi operativi, prevede in successione le fasi di: The basic procedure, in which said different operating schemes are inserted, provides in succession the phases of:

(1) far reagire bromo-acetil-piridina bromo-idrato con fenil piperazina, sotto atmosfera di azoto, in alcool metilico, in presenza di trietilammina; (1) reacting bromo-acetyl-pyridine bromo-hydrate with phenyl piperazine, under a nitrogen atmosphere, in methyl alcohol, in the presence of triethylamine;

(2) ridurre direttamente i chetoni ottenuti in 1 con NaBH4 ad alcoli in soluzone idroalcolica (derivati a), (2) directly reducing the ketones obtained in 1 with NaBH4 to alcohols in hydroalcoholic solution (derivatives a),

(3) clorurare detti alcoli con SOCI2 in CHC13 e (3) chlorinate said alcohols with SOCI2 in CHC13 e

(4) aggiungere i cloro derivati così ottenuti, non purificati, 3 ad una soluzione alcolica di metilato od etilato sodico, ed isolare gli alcossi derivati b dalla miscela di reazione (4) adding the chlorine derivatives thus obtained, not purified, 3 to an alcoholic solution of methylated or sodium ethylate, and isolating the alkoxy derivatives b from the reaction mixture

45 45

50 50

55 55

R = beta (C,H,N~) R2 R = beta (C, H, N ~) R2

R = » » R2 R = »» R2

R = » » R2 R = »» R2

R = » » R? R = »» R?

R = » » Ro R = »» Ro

R = gamma (C3H5N-) R., R = gamma (C3H5N-) R.,

R = » » Ro o, m, p, (-OCH,) o, m, p, (-CH3) o, m, p, (-C1) o (-F) R = »» Ro o, m, p, (-OCH,) o, m, p, (-CH3) o, m, p, (-C1) or (-F)

-H -H -H -H

c (-och3) c (-och3)

(b) Derivati alcossilici (prodotti 4 e 16-20) (b) Alkoxyl derivatives (products 4 and 16-20)

Si clorurano i derivati alcolici a con SOCl2 e, il clorode-rivato ottenuto non purificato, si aggiunge ad una soluzione 60 alcolica di alchilato sodico. The alcoholic derivatives a are chlorinated with SOC1 and the chlorode-rivate obtained not purified is added to an alcoholic solution 60 of sodium alkylate.

Secondo lo schema di reazione: According to the reaction scheme:

65 r-ch-ch2-n n. oh 65 r-ch-ch2-n n. Oh

(VIII) (VIII)

5 5

624402 624402

(IX) (IX)

in cui R, X e R2 hanno le combinazioni di significati sotto indicate: wherein R, X and R2 have the combinations of meanings indicated below:

R R

= beta (C5H5N-) X = -CH3 = beta (C5H5N-) X = -CH3

R2 = R2 =

-H 10 -H 10

R R

= » » X = -C2H3 = »» X = -C2H3

R2 = R2 =

-H -H

R R

= » » X = -CH3 = »» X = -CH3

R2 = R2 =

o (-OCH,) or (-OCH,)

R R

= » » X = C2H5 = »» X = C2H5

r2 = r2 =

o (-OCH3) 15 or (-OCH3) 15

R R

» » X = -CH3 »» X = -CH3

r2 = r2 =

o (-C1) o (-C1)

R R

= » » X = C2H5 = »» X = C2H5

R, = R, =

o (-C1) o (-C1)

I piridil-etil-derivati (prodotti 1, 2, 3) possono, Pyridyl ethyl derivatives (products 1, 2, 3) can,

in parti- 20 in parts- 20

colare, anche essere preparati facendo reagire i derivati chetonici VI con idrazina in presenza di sodio secondo lo schema pour, also be prepared by reacting the VI ketone derivatives with hydrazine in the presence of sodium according to the scheme

(vi) (you)

(VII) (VII)

in cui R, R2 e n hanno le combinazioni di significati sotto indicate: wherein R, R2 and n have the combinations of meanings indicated below:

R = beta (C5H5N-) R = beta (C5H5N-)

n = 2 n = 2

R2 = -H, o (-C1), o (-OCH3) R2 = -H, or (-C1), or (-OCH3)

Si farà ora riferimento a titolo illustrativo e non limitativo ad una esemplificazione di tutti i prodotti preferiti (prodotti 1-23) indicati nella precedente tabella 1, specificando le loro proprietà fisiche, la formula bruta, e le percentuali dei singoli componenti trovate e calcolate, nonché i metodi generali di preparazione, suddivisi in quattro gruppi indicati come esempi 1, 2, 3 e 4 e riguardanti i gruppi dei derivati contraddistinti con le lettere a, b, e c. Reference will now be made by way of illustration and without limitation to an example of all the preferred products (products 1-23) indicated in table 1 above, specifying their physical properties, the brute formula, and the percentages of the individual components found and calculated, as well as the general preparation methods, divided into four groups indicated as examples 1, 2, 3 and 4 and concerning the groups of derivatives marked with the letters a, b, and c.

Esempio 1 l-[2-ossi-2-(3'-piridil)etil]-4-fenilpiperazina Example 1 l- [2-oxy-2- (3'-pyridyl) ethyl] -4-phenylpiperazine

(n. 5) (n. 5)

Gr. 28,1 (0,1 mol) di bromo-3-acetil piridina bromidrato sono solubilizzati in 500 mi di alcool metilico. A questa soluzione si aggiungono sotto corrente di azoto, agitazione a raffreddamento, 50 mi di trietilammina e successivamente gr. 16,2 (0,1 mol) di N-fenil piperazina solubilizzata in 50 mi di alcool metilico. Gr. 28.1 (0.1 mol) of bromine-3-acetyl pyridine hydrochloride are solubilized in 500 ml of methyl alcohol. 50 ml of triethylamine and subsequently gr. Are added to this solution under a stream of nitrogen, stirring under cooling. 16.2 (0.1 mol) of N-phenyl piperazine solubilized in 50 ml of methyl alcohol.

Durante l'aggiunta la temperatura della reazione è mantenuta a 5°-10°C, si lascia quindi in riposo a temperatura ambiente per 4 h. Si raffredda a 0° ed a questa temperatura, During the addition the reaction temperature is maintained at 5 ° -10 ° C, it is then left to rest at room temperature for 4 h. It cools down to 0 ° and at this temperature,

40 sempre sotto agitazione, si fa sgocciolare una soluzione di gr. 7,5 di NaBH4 in 100 mi di acqua. 40 always under stirring, a solution of gr. 7.5 of NaBH4 in 100 ml of water.

Terminata l'aggiunta si tiene la miscela di reazione sotto agitazione a temperatura ambiente per 1 h. Si concentra fino a piccolo volume, si acidifica con H2S04 diluito, si tratta 45 con carbone, si filtra e si alcalinizza con idrato di litio. Once the addition is complete, the reaction mixture is kept under stirring at room temperature for 1 h. It is concentrated up to a small volume, acidified with diluted H2SO4, treated 45 with carbon, filtered and alkalized with lithium hydrate.

Si estrae l'olio separatosi con CHCIa, si secca il CHC13 su NaS04 e si evapora il solvente; rimane un olio denso che cristallizza per riposo. The oil separated with CHCIa is extracted, the CHC13 is dried over NaS04 and the solvent is evaporated; it remains a thick oil that crystallizes by rest.

so P.M. = 283,38 p.f. = 124-26° (da etile acetato) Resa = 58% I know P.M. = 283.38 m.p. = 124-26 ° (from ethyl acetate) Yield = 58%

per: C17H2iN30 for: C17H2iN30

Calcolato: C 72,05 H 7,47 N 14,83 Trovato. C 72,13 H 7,70 N 14,89 55 In modo analogo sono stati sintetizzati: Calculated: C 72.05 H 7.47 N 14.83 Found. C 72.13 H 7.70 N 14.89 55 In a similar way, the following have been summarized:

1 -[2-ossi-2-(3'-piridil)-etil]-4-(o-metossifenil)-piperazina (no. 6) P.M. = 313,40 p.f. = 90-91° (da etilacetato) Resa = 50% per: C18H23N,302 60 Calcolato: C 68,98 H 7,40 N 13,41 Trovato: C 69,23 H 7,73 N 13,35 1 - [2-oxy-2- (3'-pyridyl) -ethyl] -4- (o-methoxyphenyl) -piperazine (no. 6) P.M. = 313.40 m.p. = 90-91 ° (from ethyl acetate) Yield = 50% for: C18H23N, 302 60 Calculated: C 68.98 H 7.40 N 13.41 Found: C 69.23 H 7.73 N 13.35

1 -[ 2-ossi-2-(3'-piridil)-etii]-4-(m-metossifenil)-piperazina (no. 7) 1 - [2-oxy-2- (3'-pyridyl) -etii] -4- (m-methoxyphenyl) -piperazine (no. 7)

65 P.M. = 313,40 p.f. = 97-99° (da ligroina) Resa = 52% per: C18H23Ni302 65 P.M. = 313.40 m.p. = 97-99 ° (from ligroin) Yield = 52% for: C18H23Ni302

Calcolato: C 68,98 H 7,40 N 13,41 Trovato: C 68,86 H 7,62 N 13,56 Calculated: C 68.98 H 7.40 N 13.41 Found: C 68.86 H 7.62 N 13.56

624402 624402

6 6

l-[ 2-ossl-2-(3'-piridil)-etil]-4-(p-metossifenil)piperazina (no. 8) l- [2-oxl-2- (3'-pyridyl) -ethyl] -4- (p-methoxyphenyl) piperazine (no. 8)

P.M. = 313,40 p.f. = 136° (daligroina) Resa = 51% per; C;sMi;?ST:X)2 P.M. = 313.40 m.p. = 136 ° (daligroin) Yield = 51% for; C; SMI;? ST: X) 2

Calcolato: C 68,98 H 7,40 N 13,41 Trovato: C 69,13 H 7,35 N 13,75 Calculated: C 68.98 H 7.40 N 13.41 Found: C 69.13 H 7.35 N 13.75

l-[2-ossi-2-(3'-piridil)-etil]-4-(o,toluil)-piperazina (no. 9) P.M. = 297,40 p.f. = 113-114° (daligroina) Resa = 53% per: Ci8H23N.30 l- [2-oxy-2- (3'-pyridyl) -ethyl] -4- (o, toluil) -piperazine (no. 9) P.M. = 297.40 m.p. = 113-114 ° (daligroin) Yield = 53% for: Ci8H23N.30

Calcolato: C 72,70 H 7,80 N 14,13 Trovato: C 72,94 H 7,99 N 14,38 Calculated: C 72.70 H 7.80 N 14.13 Found: C 72.94 H 7.99 N 14.38

l-[2-ossi-2-(3'-piridil)-etil]-4-(m,toluil)-piperazina (no. 10) P.M. = 297,40 p.f. = 81° (da ligroina) Resa = 52% per: ClgH23NeO l- [2-oxy-2- (3'-pyridyl) -ethyl] -4- (m, toluil) -piperazine (no. 10) P.M. = 297.40 m.p. = 81 ° (from ligroin) Yield = 52% for: ClgH23NeO

Calcolato: C 72,70 H 7,80 N 14,13 Trovato: C 72,89 H 8,21 N 14,28 Calculated: C 72.70 H 7.80 N 14.13 Found: C 72.89 H 8.21 N 14.28

l-[2-ossi-2-(3'-piridil)-etil]-4-(p,toluil)-piperazina (no. 11) P.M..= 297,40 p.f. = 142° (da ligroina) Resa = 60% per: ClsH23N,sO l- [2-oxy-2- (3'-pyridyl) -ethyl] -4- (p, toluil) -piperazine (no. 11) P.M .. = 297.40 m.p. = 142 ° (from ligroin) Yield = 60% for: ClsH23N, sO

Calcolato: C 72,70 H 7,80 N 14,13 Trovato: C 72,53 H 8,07 N 13,76 Calculated: C 72.70 H 7.80 N 14.13 Found: C 72.53 H 8.07 N 13.76

l-l2-ossi-2-(3'-piridil)-etil]-4-(o,clorofenil)-piperazina (no. 12) P.M. = 317,50 p.f. = 131-133° (da ligroina) Resa = 62% per: Ci7H20OCI N3 l-l2-oxy-2- (3'-pyridyl) -ethyl] -4- (or, chlorophenyl) -piperazine (no. 12) P.M. = 317.50 m.p. = 131-133 ° (from ligroin) Yield = 62% for: Ci7H20OCI N3

Calcolato: C 64,27 H 6,35 N 13,23 Trovato: C 64,10 H 6,64 N 12,98 Calculated: C 64.27 H 6.35 N 13.23 Found: C 64.10 H 6.64 N 12.98

/-/ossi-2-(3'-piridil)etil]-4-(m-clorofenil)-piperazina (no. 13) P.M. = 317,50 p.f. = 101-103° (da etilacetato) Resa = 50% / - / oxy-2- (3'-pyridyl) ethyl] -4- (m-chlorophenyl) -piperazine (no. 13) P.M. = 317.50 m.p. = 101-103 ° (from ethyl acetate) Yield = 50%

per: C17H20ON3C1 for: C17H20ON3C1

Calcolato: C 64,27 H 6,35 N 13,23 Trovato: C 64,30 H 6,45 N 13,20 Calculated: C 64.27 H 6.35 N 13.23 Found: C 64.30 H 6.45 N 13.20

l-[ossi-2-(3'-piridil)etil]-4-(p-clorofenil)-piperazina (no. 14) P.M. = 317,50 p.f. = 135-136° (da etilacetato) Resa = 56% l- [oxy-2- (3'-pyridyl) ethyl] -4- (p-chlorophenyl) -piperazine (no. 14) P.M. = 317.50 m.p. = 135-136 ° (from ethyl acetate) Yield = 56%

per: C17H20OC1N3 for: C17H20OC1N3

Calcolato: C 64,27 H 6,35 N 13,23 Trovato: C 64,33 H 6,71 N 12,97 Calculated: C 64.27 H 6.35 N 13.23 Found: C 64.33 H 6.71 N 12.97

l-[ossi-2-(3'-piridil)etil]-4-(o-fluorofenil)-piperazina (no. 15) P.M. = 301,37 p.f. = 85°-87° (da ligroina) Resa = 57% per: CI7H2nFN30 l- [oxy-2- (3'-pyridyl) ethyl] -4- (o-fluorophenyl) -piperazine (no. 15) P.M. = 301.37 m.p. = 85 ° -87 ° (from ligroin) Yield = 57% for: CI7H2nFN30

Calcolato: C 67,75 H 6,69 N 13,95 Trovato: C 67,71 H 6,85 N 14,09 Calculated: C 67.75 H 6.69 N 13.95 Found: C 67.71 H 6.85 N 14.09

l-[2-ossi-2-(4'-piridil)etil]-4-fenilpiperazina (no. 22) P.M. = 283,40 p.f. = 108° (da ligroina) Resa = 45% per: C17H.MN,,0 l- [2-oxy-2- (4'-pyridyl) ethyl] -4-phenylpiperazine (no. 22) P.M. = 283.40 m.p. = 108 ° (from ligroin) Yield = 45% for: C17H.MN ,, 0

Calcolato: C 72,05 H 7,47 N 14,83 Trovato: C 71,81 H 7,86 N 14,56 Calculated: C 72.05 H 7.47 N 14.83 Found: C 71.81 H 7.86 N 14.56

l-[ 2-ossi-2-(4'-piridil)etil ]-4-(o,metossifenil)-piperazina (no. 21) l- [2-oxy-2- (4'-pyridyl) ethyl] -4- (or, methoxyphenyl) -piperazine (no. 21)

P.M. = 313,40 p.f. = 127° (da etilacetato) Resa = 40% per: C,8H.,3N.302 P.M. = 313.40 m.p. = 127 ° (from ethyl acetate) Yield = 40% for: C, 8H., 3N.302

Calcolato: C 68,98 H 7,41 N 13,42 Trovato: C 68,73 H 7,80 N 13,38 Calculated: C 68.98 H 7.41 N 13.42 Found: C 68.73 H 7.80 N 13.38

Esempio n. 2 l-[2-metossi-2-(3'piridil)etil]-4-fenilpiperazina Example n. 2 l- [2-methoxy-2- (3'piridil) ethyl] -4-phenylpiperazine

(n. 16) (n. 16)

5 5

Gr. 5,68 di l-[2-ossi-2-(3'piridil)etil]-4-fenilpiperazina (0,02 mol) sono solubilizzati in 200 ml di CHC13. Gr. 5.68 of l- [2-oxy-2- (3'piridil) ethyl] -4-phenylpiperazine (0.02 mol) are solubilized in 200 ml of CHC13.

Si porta la soluzione a 0° e si satura con HCl gassoso. Si aggiungono quindi sotto agitazione lentamente 4,4 mi 10 di SOCl2 (0,06 mol) sciolti in 20 mi di CHC13. The solution is brought to 0 ° and saturated with gaseous HCl. 4.4 ml 10 of SOCl2 (0.06 mol) dissolved in 20 ml of CHC13 are then added under stirring slowly.

Si tiene per h a temperatura ambiente e 3 h a ricadere. It is kept for h at room temperature and 3 h at reflux.

Si porta a secco, si riprende il residuo con la quantità minima di CH3OH a questa soluzione si addiziona lenta-15 mente e sotto raffreddamento a metilato di sodio in alcole metilico. (3,5 gr di Na in 75 mi di CHaOH). The mixture is dried, the residue is taken up with the minimum amount of CH3OH and slowly added to this solution and under cooling with sodium methylate in methyl alcohol. (3.5 g of Na in 75 ml of CHaOH).

Si tiene a ricadere per 3 h, si distilla il solvente ed il residuo è ripreso con 20 mi di H„0. The mixture is kept under reflux for 3 h, the solvent is distilled off and the residue is taken up in 20 ml of H? O.

Si estrae la soluzione acquosa per 2 volte con etere. La 20 soluzione eterea è portata a secco ed il residuo oleoso è distillato sotto vuoto. The aqueous solution is extracted 2 times with ether. The 20 ethereal solution is dried and the oily residue is distilled under vacuum.

Il distillato cristallizza per riposo. The distillate crystallizes by rest.

P.M. = 297,40 p.f. = 69-70° (da esano) Resa = 42% 25 Per: C.MO P.M. = 297.40 m.p. = 69-70 ° (from hexane) Yield = 42% 25 For: C.MO

Calcolato: C 72,70 H 7,80 N 14,13 Trovato: C 72,45 H 7,90 N 14,40 Calculated: C 72.70 H 7.80 N 14.13 Found: C 72.45 H 7.90 N 14.40

In modo analogo sono stati sintetizzati: 30 l-[2-etossi-2-(3'-piridil)etilj-4-fenilpiperazina (no. 17) P.M. = 311,40 p. eboll. = 185° (0,1 mm/Hg) Resa = 46% Similarly, the following were synthesized: 30 l- [2-ethoxy-2- (3'-pyridyl) ethyl-4-phenylpiperazine (no. 17) P.M. = 311.40 p. eboll. = 185 ° (0.1 mm / Hg) Yield = 46%

per. Cj,,H25N30 for. Cj ,, H25N30

Calcolato: C 73,29 H 8,09 N 13,50 35 Trovato: C 73,42 H 8,52 N 13,62 Calculated: C 73.29 H 8.09 N 13.50 35 Found: C 73.42 H 8.52 N 13.62

1 -[ 2-metossi-2-(3'-piridil)etil]-4-( o,metossifenil)-piperazina (no. 18) 1 - [2-methoxy-2- (3'-pyridyl) ethyl] -4- (or, methoxyphenyl) -piperazine (no. 18)

P.M. = 327,40 p. eboll. = 180-185° (0,2 mm/Hg) Resa 40 = 50% P.M. = 327.40 p. eboll. = 180-185 ° (0.2 mm / Hg) Yield 40 = 50%

per: Ci8H25Ns02 for: Ci8H25Ns02

Calcolato: C 69,71 H 7,7 N 12,84 Trovato: C 69,76 H 8,01 N 12,83 Calculated: C 69.71 H 7.7 N 12.84 Found: C 69.76 H 8.01 N 12.83

45 45

l-[ 2-etossi-2-(3'-piridiljetilJ-4-(o,metossifenil)-piperazina (no. 19) l- [2-ethoxy-2- (3'-pyridyljetylJ-4- (or, methoxyphenyl) -piperazine (no. 19)

P.M. =341,40 p. eboll. = 190° (0,2 mm/Hg) Resa = 45% P.M. = 341.40 p. eboll. = 190 ° (0.2 mm / Hg) Yield = 45%

50 per: C20H27N3O2 50 for: C20H27N3O2

Calcolato: C 70,34 H 7,97 N 12,30 Trovato: C 70,10 H 8,28 N 12,61 Calculated: C 70.34 H 7.97 N 12.30 Found: C 70.10 H 8.28 N 12.61

1 -[ 2-metossi-2-(3'-piridil)etil]-4-( o,clorojenil)-piperazina 55 (no. 20) 1 - [2-methoxy-2- (3'-pyridyl) ethyl] -4- (or, chlorojenyl) -piperazine 55 (no. 20)

P.M. = 331,80 p. eboll. = 180° (0,2 mm/Hg) Resa = 52% P.M. = 331.80 p. eboll. = 180 ° (0.2 mm / Hg) Yield = 52%

per: C18H22N3OCl for: C18H22N3OCl

Calcolato: C 65,14 H 6,68 N 12,66 60 Trovato: C 65,42 H 7,08 N 12,78 Calculated: C 65.14 H 6.68 N 12.66 60 Found: C 65.42 H 7.08 N 12.78

l-[2-etossi-2-(3'-piridil)etil]-4-(o,clorofenil)-piperazina (no. 4) P.M. = 345,80 p. eboll. = 170-175° (0,2 mm/Hg) Resa 65 = 42% l- [2-ethoxy-2- (3'-pyridyl) ethyl] -4- (or, chlorophenyl) -piperazine (no. 4) P.M. = 345.80 p. eboll. = 170-175 ° (0.2 mm / Hg) Yield 65 = 42%

per: CI(1H2<N,OCI for: CI (1H2 <N, OCI

Calcolato: C 65,98 H 6,99 N 12,15 Trovato: C 65,98 H 7,22 N 12,07 Calculated: C 65.98 H 6.99 N 12.15 Found: C 65.98 H 7.22 N 12.07

Esempio n. 3 l-[2-(3'piridil)etil]-4-(o,metossifenil)piperazina Example n. 3 l- [2- (3'piridil) ethyl] -4- (or, methoxyphenyl) piperazine

(n. 2) (n. 2)

Per la preparazione dei derivati 1, 2, 3 è necessario isolare i chetoni relativi alla formula VI dello schema I. For the preparation of derivatives 1, 2, 3 it is necessary to isolate the ketones relating to formula VI of scheme I.

Il loro isolamento si esegue conducendó la reazione come indicato nell'esempio n. 1 fino al punto in cui la miscela di reazione è tenuta sotto agitazione per 4 h a temperatura ambiente. Their isolation is carried out by conducting the reaction as indicated in example n. 1 to the point where the reaction mixture is kept under stirring for 4 h at room temperature.

A questo punto si distilla sotto vuoto ed il residuo è ripreso con etere. At this point it is distilled under vacuum and the residue is taken up in ether.

Per evaporazione del solvente rimane un olio che per riposo cristallizza. By evaporation of the solvent, an oil remains which crystallizes by rest.

Si isolano in questo modo: They isolate themselves like this:

(4-fenil-piperazinil)metil-3'-piridil-chetone P.M. = 281,40 p.f. = 103-104° (da esano) Resa = 67% per: C17H19N30 (4-phenyl-piperazinyl) methyl-3'-pyridyl-ketone P.M. = 281.40 m.p. = 103-104 ° (from hexane) Yield = 67% for: C17H19N30

Calcolato: C 72,56 H 6,81 N 14,93 Trovato: C 72,93 H 7,29 N 14,88 Calculated: C 72.56 H 6.81 N 14.93 Found: C 72.93 H 7.29 N 14.88

[4-(o-clorofenil)piperazinil]metil-3'-piridil-chetone P.M. = 315,50 p.f. = 81-83° (da esano) Resa = 70% per: C17H18N3OCl [4- (o-chlorophenyl) piperazinyl] methyl-3'-pyridyl-ketone P.M. = 315.50 m.p. = 81-83 ° (from hexane) Yield = 70% for: C17H18N3OCl

Calcolato: N 13,32 Trovato: N 13,48 Calculated: N 13.32 Found: N 13.48

[4-(o-metossifenil)piperazinil]metil-3'-piridil-chetone P.M. = 311,40 p.f. = 98° (dae sano) Resa = 72% per: C]gH21N302 [4- (o-methoxyphenyl) piperazinyl] methyl-3'-pyridyl-ketone P.M. = 311.40 m.p. = 98 ° (healthy dae) Yield = 72% for: C] gH21N302

Calcolato: N 13,50 Trovato: N 13,72 Calculated: N 13.50 Found: N 13.72

Gr. 9,4 di [4-(o-metossifenil)piperaziniI]metil-3'-piridil--chetone (0,03 mol) e 75 mi di N2H4 al 98% (0,15 mol) sono addizionati sotto agitazione ad una soluzione di gr. 4,14 di Na (0,18 mol) in 80 mi di dietilenglicole. Gr. 9.4 of [4- (o-methoxyphenyl) piperaziniI] methyl-3'-pyridyl - ketone (0.03 mol) and 75 ml of 98% N2H4 (0.15 mol) are added under stirring to a solution of gr. 4.14 of Na (0.18 mol) in 80 ml of diethylene glycol.

Si scalda, sempre sotto agitazione, a 120°-130° per 2 h; a questo punto si porta la temperatura a 180-190° allontanando l'acqua e l'idrazina in eccesso. The mixture is heated, always under stirring, at 120 ° -130 ° for 2 h; at this point the temperature is brought to 180-190 ° removing the excess water and hydrazine.

Si mantiene la temperatura a 180°-190° per 3-4 h e si distilla il solvente sotto vuoto. The temperature is maintained at 180 ° -190 ° for 3-4 h and the solvent is distilled off under vacuum.

Il residuo è ripreso con acqua e la soluzione estratta con etere. The residue is taken up with water and the solution extracted with ether.

624402 624402

Gli estratti eterei sono portati a secco ed il residuo è so-lubilizzato in HCl diluito. La soluzione acida è estratta con CHC13 ed etere. The ethereal extracts are dried and the residue is dissolved in diluted HCl. The acid solution is extracted with CHC13 and ether.

I liquidi organici sono allontanati e la soluzione acida, The organic liquids are removed and the acid solution,

dopo trattamento con carbone, è alcalinizzata con LiOH diluito. after treatment with coal, it is alkalized with diluted LiOH.

Precipita un olio che cristallizza. Si distilla sotto vuoto. 178°-182° a 0,2 mm Hg. An oil that crystallizes precipitates. It is distilled under vacuum. 178 ° -182 ° at 0.2 mm Hg.

P.M. = 297,70 p.f. = 59°-60° (da esano) Resa = 45% per: C!SHK,Nl3lO P.M. = 297.70 m.p. = 59 ° -60 ° (from hexane) Yield = 45% for: C! SHK, Nl3lO

Calcolato: C 72,70 H 7,8 N 14,13 Trovato: C 72,45 H 7,9 N 14,37 In modo analogo sono preparati, partendo dai relativi chetoni: Calculated: C 72.70 H 7.8 N 14.13 Found: C 72.45 H 7.9 N 14.37 In a similar way they are prepared, starting from the related ketones:

l-[2-(3'-piridil)etil]-4-fenilpiperazina (no. 1) P.M. = 267,40 p.f. = 66-67° (da esano) Resa = 50% per: C17H21N3 l- [2- (3'-pyridyl) ethyl] -4-phenylpiperazine (no. 1) P.M. = 267.40 m.p. = 66-67 ° (from hexane) Yield = 50% for: C17H21N3

Calcolato: C 76,36 H 7,92 N 15,72 Trovato: C 76,48 H 8,16 N 15,86 Calculated: C 76.36 H 7.92 N 15.72 Found: C 76.48 H 8.16 N 15.86

I-[2-(3'-piridil)etilj-4-(o,clorofenil)-piperazina (no. 2) P.M. = 301,80 p.f. = 72° (da esano) Resa = 53% per: C17H2„N3C1 I- [2- (3'-pyridyl) ethyl-4- (or, chlorophenyl) -piperazine (no. 2) P.M. = 301.80 m.p. = 72 ° (from hexane) Yield = 53% for: C17H2 „N3C1

Calcolato: C 67,65 H 6,68 N 13,93 Trovato: C 67,76 H 6,85 N 14,12 Calculated: C 67.65 H 6.68 N 13.93 Found: C 67.76 H 6.85 N 14.12

Esempio 4 Example 4

l-[2-isopropilossi-2-(3'-piridìl)jetìl-4-(o-metossifenil)--piperazina l- [2-isopropyloxy-2- (3'-pyridyl) Jetil-4- (o-methoxyphenyl) - piperazine

In modo analogo di esempio 2 si prepara il derivato della formula VI, in cui la sostituzione del nucleo piridile è in posizione 3, e X è In a similar way of example 2 the derivative of formula VI is prepared, wherein the replacement of the pyridyl nucleus is in position 3, and X is

yCH3 -CH yCH3 -CH

NCH3 NCH3

eR2è o-(OCH3). eR2 is o- (OCH3).

P.M. = 355,48 p.f. = 93-96° Resa = 30% per: C21H2!)N302 P.M. = 355.48 m.p. = 93-96 ° Yield = 30% for: C21H2!) N302

Calcolato: "c 70,95 H 8,2 N 11,82 Trovato: C 70,92 H 8,33 N 11,73 Calculated: "c 70.95 H 8.2 N 11.82 Found: C 70.92 H 8.33 N 11.73

7 7

5 5

Î0 I0

15 15

20 20

25 25

30 30

35 35

40 40

45 45

V V

Claims (6)

624402 624402 2 2 RIVENDICAZIONI 1. Procedimento per la preparazione di nuovi derivati eterociclici della 4-fenil-piperazina-l-alchil-sostituita di formula IV CLAIMS 1. Process for the preparation of new heterocyclic derivatives of 4-phenyl-piperazine-1-alkyl-substituted of formula IV (IV) (IV) OH OH m cui m cui R, è -H, -CI, -F, -CH3, -OCH:ì; R, is -H, -Cl, -F, -CH3, -OCH: ì; caratterizzato dal fatto di characterized by the fact of A) far reagire bromo-acetil-piridina bromidrato della formula II A) reacting bromo-acetyl-pyridine hydrochloride of formula II Br • HBr di) Br • HBr of) con fenil-piperazina della formula III with phenyl-piperazine of formula III H H - oor- - oor- -etil]-4-fenilpiperazina di formula VI, in cui la sostituzione del nucleo piridile è in posizione 3, e X è -CH3, e R2 è idrogeno. -ethyl] -4-phenylpiperazine of formula VI, wherein the replacement of the pyridyl nucleus is in position 3, and X is -CH3, and R2 is hydrogen. 4. Utilizzazione secondo la rivendicazione 2, caratteriz- Use according to claim 2, characterized 5 zata dal fatto che si prepara il l-[2-etossi-2-(3'-piridiI]-4- 5 zata by the fact that l- [2-ethoxy-2- (3'-pyridiI] -4- is prepared -fenil-piperazina di formula VI, in cui la sostituzione del nucleo piridile è in posizione 3, e X è -C2Hr„ e R2 è idrogeno. -phenyl-piperazine of formula VI, wherein the replacement of the pyridyl nucleus is in position 3, and X is -C2Hr "and R2 is hydrogen. 5. Utilizzazione secondo la rivendicazione 2, caratterizzata dal fatto che si prepara un l-[2-alcossi-2-(3'-piridil)- Use according to claim 2, characterized in that a l- [2-alkoxy-2- (3'-pyridyl) - is prepared io -etil]-4-(o,metossifenil)-piperazina di formula VI, in cui la sostituzione del nucleo piridile è in posizione 3, e R2 è o(-OOHy. io-ethyl] -4- (or, methoxyphenyl) -piperazine of formula VI, wherein the replacement of the pyridyl nucleus is in position 3, and R2 is o (-OOHy. 6. Utilizzazione secondo la rivendicazione 5, caratterizzata dal fatto che si prepara il l-[2-metossi-2-(3'-piridiI)- Use according to claim 5, characterized in that the l- [2-methoxy-2- (3'-pyridiI) - is prepared 15 -etil]-4-(o,metossifenil)-piperazina od il l-[2-etossi-2-(3'-piri-dil)-etil]-4-(o,metossifenil)-piperazina. 15-ethyl] -4- (or, methoxyphenyl) -piperazine or l- [2-ethoxy-2- (3'-piri-dil) -ethyl] -4- (or, methoxyphenyl) -piperazine. 7. Utilizzazione secondo la rivendicazione 2, caratterizzata dal fatto che si prepara un l-[2-alcossi-2-(3'-piridiI)-etil] -4-(o,clorofenil)-piperazina di formula VI in cui la sostituzio- Use according to claim 2, characterized in that a l- [2-alkoxy-2- (3'-pyridesI) -ethyl] -4- (or, chlorophenyl) -piperazine of formula VI is prepared, wherein the substitution - 20 ne del nucleo piridile è in posizione 3 e R2 è o(-Cl). 20 n and of the pyridyl nucleus is in position 3 and R2 is o (-Cl). 8. Utilizzazione secondo la rivendicazione 7, caratterizzata dal fatto che si prepara il l-[2-metossi-2-(3'-piridil)-etil]--4-(o,clorofenil)-piperazina od il l-[2-etossi-2-(3'-piridil)-etil]--4-(o,clorofeniI)-piperazina. Use according to claim 7, characterized in that l- [2-methoxy-2- (3'-pyridyl) -ethyl] - 4- (o, chlorophenyl) -piperazine or l- [2 is prepared ethoxy-2- (3'-pyridyl) ethyl] - 4- (or, chlorophenyl) piperazine. 25 25 (HI) (HI) sotto atmosfera di azoto, in alcool metilico, in presenza di trietilammina, formando il chetone della formula I under a nitrogen atmosphere, in methyl alcohol, in the presence of triethylamine, forming the ketone of the formula I 0~ 0 ~ CH, CH, (I) (THE) B) ridurre direttamente i chetoni ottenuti in (A) con NaBHj ad alcoli della formula IV in soluzione idroalcolica. 2. Utilizzazione di nuovi alcooli di formula IV B) directly reduce the ketones obtained in (A) with NaBHj to alcohols of formula IV in hydroalcoholic solution. 2. Use of new alcohols of formula IV (IV) (IV) in cui in which R2 è -H, -CI, -F, -CU,, -OCH:i; R2 is -H, -Cl, -F, -CU ,, -OCH: i; per la preparazione di nuovi derivati eterociclici della 4-fenil--piperazina-l-alchil-sostituita di formula VI for the preparation of new heterocyclic derivatives of 4-phenyl-piperazine-1-alkyl-substituted of formula VI
CH1140674A 1974-03-01 1974-08-21 Process for the preparation of novel heterocyclic derivatives of 1-alkyl-substituted 4-phenylpiperazine and use of the novel derivatives CH624402A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT892374 1974-03-01

Publications (1)

Publication Number Publication Date
CH624402A5 true CH624402A5 (en) 1981-07-31

Family

ID=11127574

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1140674A CH624402A5 (en) 1974-03-01 1974-08-21 Process for the preparation of novel heterocyclic derivatives of 1-alkyl-substituted 4-phenylpiperazine and use of the novel derivatives

Country Status (1)

Country Link
CH (1) CH624402A5 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3425477A1 (en) 1983-07-11 1985-01-31 Malesci S.p.A. Istituto Farmacobiologico, Florenz/Firenze METHOD FOR THE PRODUCTION OF 1-PYRIDYLALKYL-4-ARYLPIPERAZINES USED AS BLOOD PRESSURE-REDUCING COMPOUNDS AND THEIR SEPARATION THEREOF, AND THE STEREOISOMERS OBTAINED THEREFORE

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3425477A1 (en) 1983-07-11 1985-01-31 Malesci S.p.A. Istituto Farmacobiologico, Florenz/Firenze METHOD FOR THE PRODUCTION OF 1-PYRIDYLALKYL-4-ARYLPIPERAZINES USED AS BLOOD PRESSURE-REDUCING COMPOUNDS AND THEIR SEPARATION THEREOF, AND THE STEREOISOMERS OBTAINED THEREFORE
DE3448320C2 (en) * 1983-07-11 1991-04-11 Malesci S.P.A. Istituto Farmacobiologico, Florenz/Firenze, It

Similar Documents

Publication Publication Date Title
FI81567B (en) FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA 4-OXIPIPERIDINFOERENINGAR.
US2985657A (en) 1-(aroylalkyl)-4-heterocyclylpiperazines
US4839353A (en) Anti-ulcer substituted pyridine derivatives
ES2333482T3 (en) PIPERAZINAS AND PIPERIDINAS AS POTENTIALS OF MGLUR5.
KR20130045249A (en) Ketobenzofuran derivatives, method for synthesising same, and intermediates
PT2077996E (en) Purification process of montelukast and its amine salts
DE3906920A1 (en) PIPERAZINE DERIVATIVES OR SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS, CONTAINING THE SAME AS THE ACTIVE SUBSTANCE
US3818017A (en) 1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US3894030A (en) 1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
SU545256A3 (en) The method of obtaining derivatives of isoquinoline or their salts
HU196200B (en) Process for producing diphenyl-piperidine derivatives and pharmaceutical compositions containing them
DK156643B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NAPHTHALENESULPHONAMIDE DERIVATIVES
EP0038564A1 (en) Dibenz (b,e) oxepin derivatives and pharmaceutical compositions comprising them
NO118495B (en)
CH624402A5 (en) Process for the preparation of novel heterocyclic derivatives of 1-alkyl-substituted 4-phenylpiperazine and use of the novel derivatives
CH654001A5 (en) BENZOTHIAZOLINE COMPOUNDS.
US2997474A (en) 1-aryl-omega-(4-arylpiperazine) alkanols
SE464707B (en) NEW 2- (DIPHENYLMETHYL PIPERAZINYL) -1-PHENYLETHANOL DERIVATIVE PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION
SU512704A3 (en) The method of obtaining substituted in the 5th position of 5,10-dihydro-11 n-dibenzo (b, e) (1,4) diazepin-11-ones
US2786845A (en) Isomeric mixtures of 6-methyl-5-chloro-and 7-chloro-1, 2, 3, 4-tetrahydroquino-line derivatives
DE3132915A1 (en) 1,5-DIPHENYLPYRAZOLIN-3-ON-COMPOUNDS, METHODS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
NO143902B (en) PHENYL-LOWER ALKANOYLAMINES FOR USE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE PHENYL-LOWER ALKYLAMINES
US4308382A (en) 4-[[3-[α-Aminobenzyl]phenyl]methyl]morpholine and 4-[-[3-benzoylphenyl]ethyl]morpholine
DE2819896A1 (en) CHROME DERIVATIVES, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THE SAME
JPH05502235A (en) imidazoles

Legal Events

Date Code Title Description
PL Patent ceased